Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: BridgeBio Oncology
March 5, 2026
BridgeBio Oncology
Neutral Outlook
South San Francisco, CA
501-1,000 employees
The effect of IRA on our business and the healthcare industry in general is not yet known.
Disease Area:
Oncology
Drug Type:
Small Molecule
Source
Source
Scroll to Top